BRPI0520672A2 - formulation formulated for topical administration to the skin and method for improving skin conditions - Google Patents

formulation formulated for topical administration to the skin and method for improving skin conditions

Info

Publication number
BRPI0520672A2
BRPI0520672A2 BRPI0520672-3A BRPI0520672A BRPI0520672A2 BR PI0520672 A2 BRPI0520672 A2 BR PI0520672A2 BR PI0520672 A BRPI0520672 A BR PI0520672A BR PI0520672 A2 BRPI0520672 A2 BR PI0520672A2
Authority
BR
Brazil
Prior art keywords
skin
improving
conditions
topical administration
skin conditions
Prior art date
Application number
BRPI0520672-3A
Other languages
Portuguese (pt)
Inventor
Dahl Kyun Oh
Original Assignee
Regeron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeron Inc filed Critical Regeron Inc
Publication of BRPI0520672A2 publication Critical patent/BRPI0520672A2/en
Publication of BRPI0520672B1 publication Critical patent/BRPI0520672B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSIçãO FORMULADA PARA ADMINISTRAçãO TóPICA à PELE E METODO PARA MELHORAR AS CONDIçõES DA PELE. Trata-se de uma composição destinada a melhorar as condições da pele para aplicação tópica na pele, compreendendo hormónio de crescimento humano como ingrediente ativo, e um método para melhorar as condições da pele usando tais hormónios. A composição exposta exibe vários efeitos de condicionamento da pele, tais como o tratamento da acne, a melhoria no tratamento de rugas, a remoção de manchas escuras, a melhoria da elasticidade da pele, a estimulação do crescimento de cabelo, a prevenção do envelhecimento da pele, hidratação da pele e a proliferação de células epidérmicas estaminais da pele.COMPOSITION FORMED FOR TOPICAL SKIN ADMINISTRATION AND METHOD FOR IMPROVING SKIN CONDITIONS. It is a composition for improving skin conditions for topical application to the skin, comprising human growth hormone as an active ingredient, and a method for improving skin conditions using such hormones. The exposed composition exhibits various skin conditioning effects such as acne treatment, improvement in wrinkle treatment, removal of dark spots, improvement of skin elasticity, stimulation of hair growth, prevention of aging. skin, skin hydration and proliferation of skin stem cells.

BRPI0520672-3A 2005-10-12 2005-10-12 composition formulated for topical administration to the skin and method to improve skin conditions BRPI0520672B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2005/003402 WO2007043721A1 (en) 2005-10-12 2005-10-12 Compositions for improving skin conditions comprising human growth hormones as an active ingredient

Publications (2)

Publication Number Publication Date
BRPI0520672A2 true BRPI0520672A2 (en) 2009-05-19
BRPI0520672B1 BRPI0520672B1 (en) 2020-11-10

Family

ID=37942931

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520672-3A BRPI0520672B1 (en) 2005-10-12 2005-10-12 composition formulated for topical administration to the skin and method to improve skin conditions

Country Status (5)

Country Link
JP (1) JP5649278B2 (en)
KR (1) KR100962566B1 (en)
BR (1) BRPI0520672B1 (en)
CA (1) CA2625806C (en)
WO (1) WO2007043721A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100705981B1 (en) 2005-10-12 2007-04-10 주식회사 리제론 Compositions comprising human growth hormone for preventing hair loss or stimulating hair sprouting
KR102143557B1 (en) * 2013-08-09 2020-08-12 주식회사 리제론 Composition for improving skin conditions comprising a fragment of human heat shock protein 90a as an active ingredient
WO2016108634A2 (en) 2014-12-30 2016-07-07 (주)셀트리온 Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same
FR3034662B1 (en) * 2015-04-10 2020-08-28 Isp Investments Inc NEW USES OF HIS-D-TRP-ALA-TRP-D-PHE-LYS-NH2 SEQUENCE PEPTIDE TO DECREASE OR DELAY THE ONEST OF CELL SENESCENCE AND SIGNS OF SKIN AGING
CN106905517A (en) * 2017-04-20 2017-06-30 福建中锦新材料有限公司 A kind of polyamide 6 and its manufacture method for spinning

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001233727A (en) * 2000-02-22 2001-08-28 Musashino Meneki Kenkyusho:Kk Cosmetic
JP2002179528A (en) * 2000-12-14 2002-06-26 Japan Natural Laboratory Co Ltd Peeling cosmetic and peeling soap
JP2002234845A (en) * 2001-02-09 2002-08-23 Naris Cosmetics Co Ltd Skin care preparation
JP2004035573A (en) * 2003-10-27 2004-02-05 Kyowa Industrial Co Ltd Gommage cosmetic composition

Also Published As

Publication number Publication date
KR20090042871A (en) 2009-04-30
CA2625806C (en) 2011-08-02
JP5649278B2 (en) 2015-01-07
CA2625806A1 (en) 2007-04-19
KR100962566B1 (en) 2010-06-11
BRPI0520672B1 (en) 2020-11-10
WO2007043721A1 (en) 2007-04-19
JP2009511574A (en) 2009-03-19

Similar Documents

Publication Publication Date Title
BR112013014021A8 (en) METHODS FOR TREATMENT OF BALDNESS AND PROMOTION OF HAIR GROWTH
BRPI0700678A (en) method for improving sleep behaviors
ATE425732T1 (en) FORMULATIONS CONTAINING CERAMIDS AND/OR PSEUDOCERAMIDS AND (ALPHA-)BISABOLOL FOR THE TREATMENT OF SKIN DAMAGE
BRPI0910874B8 (en) topical formulation for use in the topical treatment of a skin condition resulting from the production of reactive oxygen species and/or for the promotion of topical wound healing in an individual's skin and use of said formulation
TW200509956A (en) Compositions and methods for treatment of rosacea
NZ593771A (en) Cyclosporine compositions for enhancing nail growth
BRPI0923589A2 (en) use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin.
CN104586695A (en) Skin care product containing cactus essence and having deep water-replenishing and moisturizing effects
BRPI0507048A (en) low-dose erythropoietin to stimulate endothelial precursor cells, regenerate organs and slow progression of target organ damage
BR112015005339A8 (en) use of miracle fruit seed oil as an active ingredient
BRPI0520672A2 (en) formulation formulated for topical administration to the skin and method for improving skin conditions
BRPI0911650B8 (en) peptide having an activity of a growth factor (gf) and a gf derivative and pharmaceutical composition for improving a skin condition and for treating a wound
JP2013173794A5 (en)
AR097599A1 (en) A COMPOSITION THAT INCLUDES GUAÇATONGA AND AROEIRA EXTRACT, ITS USE AND A METHOD FOR THE PREVENTION AND / OR TREATMENT OF SIGNS CAUSED BY SKIN AGING
HK1166737A1 (en) Topical cosmetic compositions for treating or preventing cellulite
BRPI0314066A8 (en) A NON-THERAPEUTIC COSMETIC METHOD FOR IMPROVING SKIN TURGOR IN HUMAN BEINGS OR ANIMALS, OR FOR PREVENTING OR RESTORING AGING-RELATED CHANGES IN HUMAN BEINGS OR ANIMALS, AND USE OF A MOLECULE, AN ANTIOXIDANT, OR A COMBINATION THEREOF, FOR PREPARATION OF AN ORALLY ADMINISTRABLE COMPOSITION
DE602006017094D1 (en) PEPTIDES THAT ACTUATE IN THE TREATMENT OF SKIN TREATMENTS OR THE TREATMENT OF PERIODAL DISEASES
ES2161888T3 (en) USE OF LAMINARINE AND OLIGOSACARIDS DERIVED FROM LAMINARINE IN COSMETOLOGY AND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR SKIN TREATMENT.
BR0314142A (en) Orally administrable composition for improving hair or skin quality
HRP20070183A2 (en) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
CO5060466A1 (en) METHOD OF REDUCTION OR PREVENTION OF EVIL ODOR
BR112014005966A2 (en) compositions for treating peripheral ulcers of various origins
TWI724210B (en) A longan flower extract with anti-aging, whitening, anti-allergic and cell repair
SG11201909144VA (en) Bacterial secretome for use in the treatment of skin lesions
Bader et al. Treatment of hyper-granulated limb wounds in horses

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B15Z Prolongation of time limit refused
B12F Appeal: other appeals
B11N Dismissal: publication cancelled
B09A Decision: intention to grant
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/11/2020, OBSERVADAS AS CONDICOES LEGAIS.